Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus.

Noore J, Noore A, Li B.

Antimicrob Agents Chemother. 2013 Mar;57(3):1283-90. doi: 10.1128/AAC.01650-12. Epub 2012 Dec 28.

2.

Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus.

Samuelsen O, Haukland HH, Jenssen H, Krämer M, Sandvik K, Ulvatne H, Vorland LH.

FEBS Lett. 2005 Jun 20;579(16):3421-6. Erratum in: FEBS Lett. 2005 Oct 10;579(24):5437.

3.

Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.

Choe H, Narayanan AS, Gandhi DA, Weinberg A, Marcus RE, Lee Z, Bonomo RA, Greenfield EM.

Clin Orthop Relat Res. 2015 Sep;473(9):2898-907. doi: 10.1007/s11999-015-4301-2.

4.

Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus.

Ouhara K, Komatsuzawa H, Kawai T, Nishi H, Fujiwara T, Fujiue Y, Kuwabara M, Sayama K, Hashimoto K, Sugai M.

J Antimicrob Chemother. 2008 Jun;61(6):1266-9. doi: 10.1093/jac/dkn106. Epub 2008 Mar 26.

5.

Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus.

Dean SN, Bishop BM, van Hoek ML.

BMC Microbiol. 2011 May 23;11:114. doi: 10.1186/1471-2180-11-114.

6.

Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus.

Vorland LH, Osbakk SA, Perstølen T, Ulvatne H, Rekdal O, Svendsen JS, Gutteberg TJ.

Scand J Infect Dis. 1999;31(2):173-7.

PMID:
10447328
7.

Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.

Ulvatne H, Vorland LH.

Scand J Infect Dis. 2001;33(7):507-11.

PMID:
11515760
8.

Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.

Haukland HH, Vorland LH.

J Antimicrob Chemother. 2001 Oct;48(4):569-71.

PMID:
11581240
9.

Comparative time-kill study of doxycycline, tigecycline, cefazolin and vancomycin against several clones of Staphylococcus aureus.

Herrera M, Mobilia L, Posse G, Limansky A, Ballerini V, Bantar C.

Curr Clin Pharmacol. 2013 Nov;8(4):332-9.

PMID:
23590512
10.

Increased Staphylococcus-killing activity of an antimicrobial peptide, lactoferricin B, with minocycline and monoacylglycerol.

Wakabayashi H, Teraguchi S, Tamura Y.

Biosci Biotechnol Biochem. 2002 Oct;66(10):2161-7.

11.

Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.

Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA.

Antimicrob Agents Chemother. 2006 Aug;50(8):2626-31.

12.

Specificity in killing pathogens is mediated by distinct repertoires of human neutrophil peptides.

Cederlund A, Agerberth B, Bergman P.

J Innate Immun. 2010;2(6):508-21. doi: 10.1159/000317665. Epub 2010 Sep 4.

PMID:
20820100
13.

Antimicrobial activity against intraosteoblastic Staphylococcus aureus.

Valour F, Trouillet-Assant S, Riffard N, Tasse J, Flammier S, Rasigade JP, Chidiac C, Vandenesch F, Ferry T, Laurent F.

Antimicrob Agents Chemother. 2015 Apr;59(4):2029-36. doi: 10.1128/AAC.04359-14. Epub 2015 Jan 20.

14.

Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils.

Yancey RJ, Sanchez MS, Ford CW.

Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):107-13. Review.

PMID:
1864272
15.

Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus.

Brouillette E, Grondin G, Lefebvre C, Talbot BG, Malouin F.

Vet Microbiol. 2004 Aug 6;101(4):253-62.

PMID:
15261998
16.

Evaluation of antibiotic effectiveness against Staphylococcus aureus surviving within the bovine mammary gland macrophage.

Sanchez MS, Ford CW, Yancey RJ Jr.

J Antimicrob Chemother. 1988 Jun;21(6):773-86.

PMID:
3410801
17.

Antimicrobial activity of gentamicin palmitate against high concentrations of Staphylococcus aureus.

Kittinger C, Marth E, Windhager R, Weinberg AM, Zarfel G, Baumert R, Felisch S, Kuehn KD.

J Mater Sci Mater Med. 2011 Jun;22(6):1447-53. doi: 10.1007/s10856-011-4333-4. Epub 2011 May 10.

PMID:
21556977
18.

Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella.

Amer LS, Bishop BM, van Hoek ML.

Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.

PMID:
20399752
19.

Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-lysin.

Yan J, Wang K, Dang W, Chen R, Xie J, Zhang B, Song J, Wang R.

Antimicrob Agents Chemother. 2013 Jan;57(1):220-8. doi: 10.1128/AAC.01619-12. Epub 2012 Oct 22.

Supplemental Content

Support Center